MedTrace Logo

Glasses Against Transmission of SARS-CoV-2 (COVID-19) in the Community

NCT05217797 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3717

Last updated 2023-11-13

No results posted yet for this study

Summary

In this trial the researchers plan to recruit 25,000 volunteers to be randomly allocated either wearing sunglasses or ordinary glasses in public spaces where they are close to other people, or not wear glasses in such circumstances. For each participant the trial period is 2 weeks, after which they will be asked to complete a brief questionnaire which includes questions about results of COVID-19 tests during the trial period.

Conditions

Interventions

BEHAVIORAL

Wearing glasses (any type)

Participants are asked to wear glasses in public spaces.

Sponsors & Collaborators

  • University of Basel

    collaborator OTHER

  • Norwegian Institute of Public Health

    lead OTHER_GOV

Principal Investigators

  • Atle Fretheim, PhD · Head of Centre for Epidemic Interventions Research (CEIR)

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-02
Primary Completion
2022-05-01
Completion
2022-12-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05217797 on ClinicalTrials.gov